TCL Archive “Sloppy” Cancer Control Grant Applications Turned Down At Twice NIH Disapproval Rate November 7, 1975
TCL Archive Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months September 27, 2013